German Value Set for the EQ-5D-5L

Greiner W. Der EQ-5D der EuroQol-Gruppe. In: Schöffski O, Graf von der Schulenburg JM, editors. Gesundheitsökonomische Evaluationen. 4th ed. Heidelberg, Berlin: Springer; 2012. p. 411–22.

Devlin NJ, Krabbe PFM. The development of new research methods for the valuation of EQ-5D-5L. Eur J Health Econ. 2013;14(Suppl. 1):1–3.

Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–36.

Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22:1717–27.

Pickard AS, de Leon MC, Kohlmann T, Cella D, Rosenbloom S. Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Med Care. 2007;45:259–63.

van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15:708–15.

Oppe M, Devlin NJ, van Hout B, Krabbe PFM, de Charro F. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value Health. 2014;17:445–53.

Shah K, Rand-Hendriksen K, Ramos-Goñi JM, Prause AJ, Stolk E. Improving the quality of data collected in EQ-5D-5L valuation studies: a summary of the EQ-VT research methodology programme. In: Proceedings of the 31st Scientific Plenary Meeting of the EuroQol Group; Stockholm, Sweden, September 25–26, 2014. 2015: p. 1–18. http://eq-5dpublications.euroqol.org/download?id=0_53918&fileId=54332 . Accessed 21 Aug 2017.

Stolk E, Ludwig K, Rand K, van Hout B, Ramos-Goñi JM. Overview, update and lessons learned from the international EQ-5D-5L valuation work: version 2 of the EQ-5D-5L valuation protocol. Value Health. (Submitted).

Ludwig K, Graf von der Schulenburg JM, Greiner W. Valuation of the EQ-5D-5L with composite time trade-off for the German population: an exploratory study. Health Qual Life Outcomes. 2017;15:39. https://doi.org/10.1186/s12955-017-0617-9 .

Oppe M, van Hout B. The “power” of eliciting EQ-5D-5L values: the experimental design of the EQ-VT. EuroQol working paper series. 2017;17003. http://euroqol.org/wp-content/uploads/2016/10/EuroQol-Working-Paper-Series-Manuscript-17003-Mark-Oppe.pdf . Accessed 26 Oct 2017.

Federal Statistical Office. Mikrozensus. Bevölkerung und Erwerbstätigkeit. Stand und Entwicklung der Erwerbstätigkeit in Deutschland 2014. http://www.destatis.de/DE/Publikationen/Thematisch/Arbeitsmarkt/Erwerbstaetige/StandEntwicklungErwerbstaetigkeit.html . Accessed 10 Aug 2017.

Oppe M, Rand-Hendriksen K, Shah K, Ramos-Goñi JM, Luo N. EuroQol protocols for time trade-off valuation of health outcomes. PharmacoEconomics. 2016;34:993–1004.

Devlin NJ, Tsuchiya A, Buckingham K, Tilling C. A uniform time trade off method for states better and worse than dead: feasibility study of the ‘lead time’ approach. Health Econ. 2011;20:348–61.

Janssen BMF, Oppe M, Versteegh MM, Stolk EA. Introducing the composite time trade-off: a test of feasibility and face validity. Eur J Health Econ. 2013;14(Suppl. 1):5–13.

Ramos-Goñi JM, Oppe M, Slaap B, Busschbach JJV, Stolk E. Quality control process for EQ-5D-5L valuation studies. Value Health. 2016;20:466–73.

Lin HW, Li CI, Hsu CN, Tang CH. Does time of full health in worse-than-death (WTD) tasks matter? Noordwijk; 2nd EuroQol Academy Meeting. Noordwijk, The Netherlands, 7–8 March, 2017; 2017.

Feng Y, Devlin NJ, Shah KK, Mulhern B, van Hout B. New methods for modelling EQ-5D-5L value sets: an application to English data. Health Econ. 2017. https://doi.org/10.1002/hec.3560 .

Ramos-Goñi JM, Pinto-Prades JL, Oppe M, Cabasés JM, Serrano-Aguilar P, Rivero-Arias O. Valuation and modeling of EQ-5D-5L health states using a hybrid approach. Med Care. 2014;55:51–8.

Ramos-Goñi JM, Craig B, Oppe M, van Hout B. Combining continuous and dichotomous responses in a hybrid model. EuroQol working paper series. 2016; 16002. https://euroqol.org/wp-content/uploads/working_paper_series/EuroQol_Working_Paper_Series_Manuscript_16002_-_Juan_Ramos-Goni.pdf . Accessed 21 Aug 2017.

Cameron AC, Trivedi PK. Microeconometrics using Stata. Revised ed. College Station (TX): Stata Press; 2010.

Greiner W, Claes C, Busschbach JJV, Graf von der Schulenburg JM. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ. 2005;6:124–30.

Devlin NJ, Shah KK, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ. 2017. https://doi.org/10.1002/hec.3564 .

Versteegh MM, Vermeulen KM, Evers SMAA, de Wit GA, Prenger R, Stolk EA. Dutch tariff for the five-level version of EQ-5D. Value Health. 2016;19:343–52.

Bleichrodt H. A new explanation for the difference between time trade-off utilities and standard gamble utilities. Health Econ. 2002;11:447–56.

Lancsar E, Louviere J. Deleting ‘irrational’ responses from discrete choice experiments: a case of investigating or imposing preferences? Health Econ. 2006;15:797–811.

Alemu MH, Mørkbak MR, Olsen SB, Jensen CL. Attending to the reasons for attribute non-attendance in choice experiments. Environ Resource Econ. 2013;54:333–59.